Mahindra Lifespace Developers Ltd. Share Price

Mahindra & Mahindra daily chart, ₹2,900 is a strong support

The blue trendline connects the previous swing lows, and price has repeatedly taken support around ₹2,900–₹2,950, showing that buyers have been active in this area. The current price near ₹3,160 is still above this support, so the broader structure remains protected as long as ₹2,900 holds. A bounce from ₹2,900 with strong buying volume can support a recovery toward ₹3,300–₹3,400 and then ₹3,500. However, a decisive daily/weekly close below ₹2,900 with volume would indicate a trendline breakdown and could weaken the structure significantly. In simple terms: ₹2,900 is the key demand/support zone; holding it keeps the possibility of a rebound alive, while a breakdown can signal further weakness.

See More

Mahindra Lifespaces Signs Chembur Redevelopment Pact.

— NIFTY 500 realty constituent relevant to Mumbai redevelopment. The company signed a redevelopment agreement covering seven Chembur plots, nine buildings and 133 members. The project has a 60-month completion timeline. Redevelopment agreements can improve project visibility, while execution timelines, approvals and construction costs remain key factors. Track project execution, regulatory approvals and monetisation potential when assessing redevelopment businesses.

See More

Q1FY27 Quarterly Result Announced for Mahindra Lifespace Developers Ltd.

Q1FY27 Quarterly Result Announced for Mahindra Lifespace Developers Ltd.

SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826 Total income (including other income) for Q1FY27 stood at Rs 97,754 lakh, a significant increase from Rs 4,061 lakh in Q1FY26 and a growth of 35.17% from Rs 72,321 lakh in Q4FY26. Revenue from operations for Q1FY27 was Rs 96,213 lakh, compared to Rs 3,197 lakh in Q1FY26 and Rs 66,962 lakh in Q4FY26, representing a QoQ growth of 43.68%. Profit before tax for Q1FY27 reached Rs 11,100 lakh, an increase of 166.83% YoY from Rs 4,160 lakh in Q1FY26 and a growth of 31.77% QoQ from Rs 8,424 lakh in Q4FY26. Net profit for the period for Q1FY27 was Rs 8,555 lakh, marking a 66.89% YoY growth from Rs 5,126 lakh in Q1FY26. On a QoQ basis, net profit decreased by 5.07% from Rs 9,012 lakh in Q4FY26. All this is for information This is not a buy/sell recommendation. Thank you, Technofunda24

See More

Acquisition of 15-acre land parcel in Kandivali East, Mumbai. - Mahindra Lifespace Developers Ltd

Code BSE: 532313 NSE:

Acquisition of 15-acre land parcel in Kandivali East, Mumbai Strategically located in Kandivali East, the open greenfield land parcel benefits from excellent connectivity to the Western Express Highway and existing metro corridors. The location is supported by established social infrastructure, including schools, hospitals, and retail hubs, and continues to witness strong residential absorption driven by end-user demand.

See More

Aurobindo Pharma Subsidiaries Receive US FDA Observations, Operations Remain Unaffected

Aurobindo Pharma Ltd (

) announced that the US FDA completed a pre-approval inspection of Eugia Steriles Pvt. Ltd.’s manufacturing facility in Parawada Mandal, Anakapalli District, Andhra Pradesh, conducted between June 10 and June 19, 2026, and issued five observations. Eugia Steriles, a wholly owned subsidiary of Eugia Pharma Specialities Ltd, stated that it will address the observations within the prescribed timeline and confirmed that there is no impact on the company’s financials or operations. Separately, the US FDA recently classified the inspection of Eugia Pharma Specialities’ Unit-III facility in Pashamylaram, Telangana, as “Official Action Indicated” (OAI). That inspection was carried out from January 27 to February 6, 2026, and concluded with 11 observations, with the OAI classification being communicated on June 12, 2026. Despite these regulatory developments, Aurobindo Pharma reiterated its commitment to maintaining high manufacturing quality standards across its global facilities and stated that its business operations and financial performance remain unaffected while corrective actions are being undertaken. Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.

See More

Mahindra Lifespaces Expands Mumbai Footprint with ₹5,600 Crore Project Potential and Boosts Chennai Industrial Ecosystem

Mahindra Lifespace Developers Ltd (

) has strengthened its presence in Mumbai by acquiring a 15-acre greenfield land parcel in Kandivali East, offering a development potential of around 1.8 million square feet and an estimated Gross Development Value (GDV) of approximately ₹5,600 crore. The location benefits from strong connectivity through the Western Express Highway, existing metro corridors and the upcoming Borivali–Thane Twin Tunnel, which is expected to improve access between Mumbai’s western suburbs and Thane and support long-term growth. The area also enjoys robust social infrastructure and sustained residential demand. In another development, Mahindra Industrial Park Chennai Ltd (MIPCL), a joint venture between Mahindra World City Developers Ltd and Japan’s Sumitomo Corporation, announced that YKK India Pvt. Ltd. will establish its third manufacturing facility in India at Origins by Mahindra, Chennai. The new plant will cover around 149,936 square metres and involve an investment of $150 million, with completion targeted by February 2028. With YKK India joining global manufacturers such as Mitsubishi Electric, Yanmar and Omron, the industrial cluster continues to attract international investments, further strengthening Mahindra Lifespaces’ presence across both residential and industrial real estate segments. Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.

See More